Stocknear Logo Stocknear
/
Popular
Login

Takeda Pharmaceutical Li...

14.71
0.06 (0.41%)
At close: Apr 17, 2025, 3:59 PM

Takeda Pharmaceutical Cash Flow Statement

Financials in JPY. Fiscal year is April - March.

Revenue peaked at - in undefined and hit its lowest at - in undefined. Over the past five years, it has declined by undefined%.

undefined

n/a
Fiscal Year FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
144.07B 317.04B 230.17B 376.17B 44.29B 109.01B 186.71B 115.51B
728B 664.4B 583.15B 559.67B 583.65B 272.45B 182.13B 222.79B
70.87B 60.67B 43.37B 37.66B 29.12B 20.08B 18.61B 17.41B
-145.47B 31.9B -58.09B 49.1B 21.94B 47.06B -6.53B 20.55B
120.81B -97.74B 95.4B -228.42B 23.06B -134.89B -53.49B 25.49B
-91.41B 58.05B 72.41B -9.94B -105.04B -14.12B 30.5B 27.83B
-256B -25.26B 98.61B 275.78B 94.67B 75.95B 13.4B 29.68B
716.34B 977.16B 1,123.1B 1,010.9B 669.75B 328.48B 377.85B 261.36B
-480.73B -633.69B -186.04B -236.47B -217.71B -134.11B -128.26B -112.03B
-4.74B 7.96B -21.48B 530.39B 456.66B -2,873.6B 56.75B -524.74B
-40.07B -10.15B -8.34B -12.6B -7.55B -17.1B -88.66B -82.11B
8.02B 22.25B 16.92B 74.6B 49.4B 65.03B 40.74B 75.27B
-251.66B 6.53B 808M 37.6B 11.32B 124.03B 26.08B -12.09B
-463.86B -607.1B -198.13B 393.53B 292.12B -2,835.7B -93.34B -655.69B
1.51B -325.07B -600.48B -656.06B -586.09B 3,161.5B -153.14B 471.42B
-2.33B -26.93B -77.53B -2.14B -3.74B -1.17B -18.76B -23.12B
-287.19B -279.42B -283.67B -283.36B -282.58B -142.95B -141.89B -141.69B
-66.42B -77.73B -108.59B -146.79B -132.8B -71.14B -12.44B -16.72B
-354.42B -709.15B -1,070.3B -1,088.4B -1,005.2B 2,946.2B -326.23B 289.9B
-75.73B -316.17B -116.53B 328.61B -65.11B 407.12B -46.73B -131.97B
235.61B 343.47B 937.07B 774.46B 452.04B 194.37B 249.59B 149.34B

Create Price Alert on TAK

Your price alert will notify you when the stock price is above 14.71.

Add to Watchlist